Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,847 | -27,385 | -19,697 | -9,930 | -55,851 |
| Depreciation Amortization | -898 | -919 | -716 | -349 | -1,421 |
| Accounts payable and accrued liabilities | -22 | -167 | 849 | 166 | -1,158 |
| Other Working Capital | -4,911 | -4,912 | -3,151 | -4,483 | 5,913 |
| Other Operating Activity | 6,332 | 5,336 | 1,689 | 2,125 | 9,308 |
| Operating Cash Flow | $-33,346 | $-28,046 | $-21,025 | $-12,470 | $-43,209 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 47,736 | 31,736 | 6,736 | 7,290 | -44,916 |
| Investing Cash Flow | $47,736 | $31,736 | $6,736 | $7,290 | $-44,916 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,124 | 1,124 | 1,003 | 1,003 | 388 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -560 |
| Financing Cash Flow | $1,124 | $1,124 | $1,003 | $1,003 | $-171 |
| Beginning Cash Position | 54,527 | 54,527 | 54,527 | 54,527 | 142,823 |
| End Cash Position | 70,041 | 59,341 | 41,241 | 50,351 | 54,527 |
| Net Cash Flow | $15,514 | $4,814 | $-13,286 | $-4,177 | $-88,296 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,346 | -28,046 | -21,025 | -12,470 | -43,209 |
| Free Cash Flow | -33,346 | -28,046 | -21,025 | -12,470 | -43,209 |